Clarinex-d 12 Hour Tablet, Extended Release
Product Images NDC 78206-120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clarinex-d 12 Hour (NDC 78206-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clarinex D12 01)

Chemical structure diagram of desloratadine, the active ingredient in CLARINEX-D 12 HOUR tablets, extended release, by Organon LLC.*

FDA Label Image

Chemical Structure (Clarinex D12 02)

Chemical structure diagram depicting the sulfate salt form of a compound, associated with the active ingredient pseudoephedrine sulfate in CLARINEX-D 12 HOUR tablets.*

FDA Label Image

Principal Display Panel (100 Tablet Bottle Label)

CLARINEX-D 12 HOUR extended release tablets packaging label showing the active ingredients desloratadine 2.5 mg and pseudoephedrine sulfate USP 120 mg. The label indicates a bottle containing 100 tablets, with NDC 78206-120-01. The product is for oral use and is Rx only, manufactured by Organon LLC. The label also includes tablet image imprint 'D12' and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.